American City Business Journals • yesterday
Teva Pharmaceutical Industries Ltd. and IBM said Wednesday they are "significantly expanding" their Watson Health alliance. Watson is IBM's supercomputer that combines artificial intelligence and sophisticated analytical software. The expansion of Teva (TEVA) and IBM's three-year partnership will focus on two key health care challenges: the discovery of new treatment options and improving chronic disease management.
Insider Monkey • yesterday
All three major indexes are in the red today, as the earnings results of several major companies including Apple Inc. (NASDAQ:AAPL) failed to meet expectations. Among the stocks that traders are watching are Toyota Motor Corp (ADR) (NYSE:TM), Martin Marietta Materials, Inc. (NYSE:MLM), Vulcan Materials Company (NYSE:VMC), International Business Machines Corp. (NYSE:IBM), and Teva Pharmaceutical Industries Ltd […]
optionMONSTER • yesterday
Traders are looking for a quick bounce in Teva Pharmaceutical. OptionMonster's market scanner shows that 3,800 Weekly 44 calls expiring this Friday were purchased for $0.33 to $0.65 yesterday. Volume was ...
24/7 Wall St. • yesterday
The October 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Barrons.com • 2 days ago
With the MSCI Emerging Market index up double digits this year, Morningstar says the rally “is not based on fundamentals." Investors are looking for returns in markets that have under performed in recent years, says writer Manuela Badawy, who cited a plethora of risks, from the attempted coup in Turkey that roiled markets there to fluctuating foreign exchange rates and economic risks facing commodity-dependent nations such as Nigeria and South Africa. For those investors who find the lure of higher growth in emerging markets attractive despite the risks, Morningstar's Badawy offered up a handful of stock picks and fund ideas.
Capital Cube • 7 days agoTeva Pharmaceutical Industries Ltd. : TEVA-US: Dividend Analysis : August 22nd, 2016 (record date) : By the numbers : October 20, 2016
Categories: Yahoo Finance Get free summary analysis Our analysis is based on comparing Teva Pharmaceutical Industries Ltd. with the following peers – Mylan N.V., Sanofi Sponsored ADR, Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Valeant Pharmaceuticals International Inc, Merck & Co., Inc., Pfizer Inc., Dr. Reddy’s Laboratories Ltd. Sponsored ADR, Astrazeneca PLC Sponsored ADR and Takeda Pharmaceutical ... Read more (Read more...)
Zacks • 7 days ago
Given the current scenario of increased political, media and public pressure on drug pricing, it makes sense to zero in on companies that are in the biosimilars business.
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||43.38 x 1100|
|Ask||43.40 x 800|
|Day's Range||43.03 - 43.76|
|52wk Range||41.67 - 66.55|
|1y Target Est||65.95|
|P/E Ratio (ttm)||29.05|
|Avg Vol (3m)||6,708,821|
|Dividend & Yield||1.36 (3.10%)|